Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intensive Versus Standard Blood Pressure Control in Patients With Primary Aldosteronism (Intensia-Aldo): A Multi-center, Randomized Controlled Trial

NCT07673445 is registered in ClinicalTrials.gov with Chongqing Medical University as lead sponsor.

NCT NCT07673445
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07673445 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intensive Versus Standard Blood Pressure Control in Patients With Primary Aldosteronism (Intensia-Aldo): A Multi-center, Randomized Controlled Trial
Lead sponsor
Chongqing Medical University
Phase
Not applicable
Overall status
Recruiting
Start date
July 7, 2026
Completion date
December 31, 2036
Enrollment
3,830 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary aldosteronism